GlaxoSmithKline
GSK
$45.66
Share price
1.08%
Change (1 day)
24.14%
Change (1 year)
Categories
GlaxoSmithKline (GSK) - Total assets
Total assets on the balance sheet as of March 2024 : $73.94 B
According to GlaxoSmithKline's latest financial reports the company's total assets are $73.94 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
GlaxoSmithKline - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $75.11 B | 3.04% |
| 2022-12-31 | $72.89 B | -31.73% |
| 2021-12-31 | $106.77 B | -2.61% |
| 2020-12-31 | $109.63 B | 4.91% |
| 2019-12-31 | $104.50 B | 41.78% |
| 2018-12-31 | $73.70 B | -3.28% |
| 2017-12-31 | $76.20 B | 4.45% |
| 2016-12-31 | $72.95 B | -7.88% |
| 2015-12-31 | $79.20 B | 25.14% |
| 2014-12-31 | $63.28 B | -8.83% |
| 2013-12-31 | $69.42 B | 3.54% |
| 2012-12-31 | $67.04 B | 5.21% |
| 2011-12-31 | $63.72 B | -2.25% |
| 2010-12-31 | $65.19 B | -6.01% |
| 2009-12-31 | $69.35 B | 20.13% |
| 2008-12-31 | $57.73 B | -6.35% |
| 2007-12-31 | $61.65 B | 22.87% |
| 2006-12-31 | $50.17 B | 7.33% |
| 2005-12-31 | $46.74 B | 7.56% |
| 2004-12-31 | $43.46 B | 1.48% |
| 2003-12-31 | $42.83 B | 52.92% |
| 2002-12-31 | $28.00 B | 1.65% |
| 2001-12-31 | $27.55 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 27.58% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 206.32% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 89.09% | 🇫🇷 France |
 Merck MRK | $106.67 B | 44.27% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 38.34% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $43.47 B | -41.20% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.99 B | -98.65% | 🇺🇸 USA |